Evidence Synthesis: Enabling Successful Launches, Regulatory Submissions, Key Product Developments, and Other Strategic Activities
Evidence Synthesis: Enabling Successful Launches, Regulatory Submissions, Key Product Developments, and Other Strategic Activities
2 PagesIQVIA’s evidence synthesis services support launches, HTA submissions, regulatory filings, and strategic product development. Services include systematic literature reviews, competitor benchmarking, indirect treatment comparisons (ITCs), and meta-analysis. Projects are led by PhD-level staff, integrated with real-world datasets, and supported by NLP/AI to accelerate reviews. IQVIA ensures global, regulatory-grade evidence aligned with FDA, EMA, and HTA requirements. The approach enhances product value stories, strengthens submissions, and helps companies demonstrate clinical and economic value.
